BACH2 and autoimmune pancreatitis: In a straightforward approach, we treated MRL/MpJ mice with poly I:C-induced AIP with the MAP3K7 inhibitor takinib [14] and the JAK inhibitor tofacitinib, which preferentially inhibits the expression of Bach2-regulated pro-inflammatory genes [16].